ART Advanced Research Technologies Inc. (CC:ARA) Announces Alerion Biomedical, Inc.. Acquisition
2/15/2006 12:03:02 PM
More...
|
Alerion Biomedical, Inc. Reports That Fenestra(TM), Its New Contrast Agent For Pre-Clinical Imaging, Was Featured In Multiple Presentations And Abstracts At The Annual Meeting Of The Academy Of Molecular Imaging
10/19/2005 5:13:05 PM
More...
|
Alerion Biomedical, Inc. Release: Fenestra(TM), The Leading Contrast Agent For microCT, To Be Featured In Multiple Presentations At The Medical Imaging 2005 Symposium Held By The International Society For Optical Engineering
10/19/2005 5:12:41 PM
More...
|
Alerion Biomedical, Inc. And Vanderbilt University Medical Center Receive National Institutes of Health (NIH) STTR Grant To Develop Biochemically-Activated MRI Contrast Agents
10/19/2005 5:11:51 PM
More...
|
Alerion Biomedical, Inc. Release: New Contrast Agent Fenestra(TM) To Be Featured In Multiple Presentations At The Annual Meeting Of The Society For Molecular Imaging
10/19/2005 5:10:10 PM
More...
|
Alerion Biomedical, Inc. Announces The Market Launch Of Fenestra(TM), The First-Ever Imaging Agent Specifically Designed For Pre-Clinical Computed Tomography
10/19/2005 5:09:00 PM
More...
|